Steve E. Krognes - 13 Jun 2024 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLRX	Common Stock (Right to Buy)	Award	$0	+53,528		$0.000000	53,528	13 Jun 2024	Common Stock	53,528	$13.06	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	1/36th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of June 13, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.